Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05884190 · ClinicalTrials.gov registry record · NA

Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension

A NA study of Postpartum Hypertension, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
6,030
Enrollment target
3
Study locations

NCT05884190 is a NA study of Postpartum Hypertension that is actively recruiting participants, run by Yale University. The registered enrollment target is 6,030 participants. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05884190, a NA study of Postpartum Hypertension, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
6,030 participants
Enrollment target
3
Study locations

Study Summary

The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.

Conditions Studied

Interventions

  • OTHER Remote Medical Model (RMM)
  • OTHER Community Health Model (CHM)
  • OTHER SoC

Study Locations (3)

Connecticut

  • Yale New Haven Hospital - New Haven

Massachusetts

  • University of Massachusetts Memorial Health - Worcester

New York

  • Oishei Children's Hospital University at Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 6,030 participants
Start Date 2023-06-12
Est. Completion 2027-10
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05884190

The ClinicalTrials.gov registry entry for NCT05884190 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 6,030 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postpartum Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Remote Medical Model (RMM) is the first listed.

NCT05884190 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT05884190 about?

NCT05884190 is a clinical study titled "Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension". The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The...

What is the current status of trial NCT05884190?

This trial is currently recruiting. It is a NA study. The enrollment target is 6,030 participants. The study started on 2023-06-12. Estimated completion is 2027-10.

What conditions does trial NCT05884190 study?

This clinical trial studies the following conditions: Postpartum Hypertension.

What interventions are being tested in trial NCT05884190?

The interventions under investigation include: Remote Medical Model (RMM) (OTHER), Community Health Model (CHM) (OTHER), SoC (OTHER).

Who is sponsoring clinical trial NCT05884190?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05884190 being conducted?

This trial has 3 study locations across Connecticut, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.